Fortitude Family Office »

Janux Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.8k 207 37.65
2023-12-31 $2.5k 237 10.73

More positions owned by Fortitude Family Office

Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Vanguard Mid-cap Etf Etf (VO)
Ishares Tips Bond Etf Etf (TIP)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares Core S&p Small Cap Etf Etf (IJR)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Jpmorgan Ultra-short Income Etf Ultra Short Income Fund Etf (JPST)
Kkr & Co Stock (KKR)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Vanguard Ftse Emerging Markets Etf Etf (VWO)

View all positions for Fortitude Family Office

Top funds holding Janux Therapeutics

RA Capital Management
BVF
OrbiMed Advisors
Citadel Advisors
Henderson Group
Vanguard Group
Samsara BioCapital
Alyeska Investment Group
Millennium Management
Squarepoint Ops
HPM Partners
Zacks Investment Management
Capstone Investment Advisors
DekaBank Deutsche Girozentrale
Bank of New York Mellon

View all funds holding Janux Therapeutics